In a paper published on Wednesday, researchers re-analysed the Pfizer covid “vaccine” phase 3 trial data and found more serious adverse events among those in the vaccine group.

This is not what published reports from Pfizer’s phase 3 trials said. “Many key trial findings were either misreported or omitted entirely from published reports,” the researchers said.

Seven researchers – M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, Jessica Rose, Kris Denhaerynck, Steve Kirsch and Peter A. McCullough – set out to re-analyse Pfizer’s trial data because:

our understanding of covid vaccinations and their impact on health and mortality has evolved substantially since the first vaccine rollouts; and,
problems with the methods, execution, and reporting of the pivotal phase 3 trials have emerged.